Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism CCR1 antagonists(C-C chemokine receptor type 1 antagonists), CCR3 antagonists(C-C chemokine receptor type 3 antagonists), CCR5 antagonists(C-C chemokine receptor type 5 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 16 Apr 2023 |